Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Birgit Assmus

Justus-Liebig University of Giessen, Giessen (Germany)

5 More presentations in this session

Presentation thumbnail

Atrial fibrillation ablation is the fifth pillar in the treatment of HFrEF: pro

Professor L. Di Biase (The Bronx, US)

Presentation thumbnail

Atrial fibrillation ablation is the fifth pillar in the treatment of HFrEF: con

Professor L. Stevenson (Nashville, US)

Presentation thumbnail

Atrial fibrillation ablation is the fifth pillar in the treatment of HFrEF - discussion

Presentation thumbnail

Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: con

Professor L. Kober (Copenhagen, DK)

Presentation thumbnail

Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF - discussion

Access the full session

Session thumbnail

Great Debates: electrophysiology in HFrEF - the burning questions

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Has the sudden cardiac death landscape changed? Continuing our patient’s protection mission

Congress Presentation

Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: con

Congress Presentation

ICD therapy is indicated for all patients with non-ischaemic cardiomyopathy and severely impaired LVEF: con

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources